Navigation Links
NYU Langone Medical Center researcher named Howard Hughes Investigator
Date:5/9/2013

NEW YORK, May 9, 2013 The Howard Hughes Medical Institute (HHMI) has announced the appointment of Evgeny Nudler, PhD, to the 2013 class of HHMI Investigators.The appointment ranks as one of the highest honors that can be bestowed on a biomedical research scientist. Dr. Nudler, the Julie Wilson Anderson Professor of Biochemistry in the Department of Biochemistry and Molecular Pharmacology at NYU Langone Medical Center, was selected among more than 1,200 applicants for his work on numerous biochemical frontiers, including the role of bacterial gases in antibiotic resistance and the interplay between RNA transcription and the cellular response to stress.

"The depth and breadth of Evgeny Nudler's research is absolutely remarkable," said Dafna Bar-Sagi, PhD, senior vice president and vice dean for science and chief scientific officer at NYU School of Medicine. "The five highly unique projects underway in his lab hold promise for a broad range of diseases, from cancer and heart disease to bacterial infections and Alzheimer's. His versatility and range are invaluable, and his selection as an HMMI Investigator is richly deserved."

Most recently, Dr. Nudler and his colleagues have discovered how the roundworm exploits bacteria within its gut to harness the life-extending benefits of nitric oxide, a gas implicated in a wide range of physiological functions from blood pressure to immune response in mammals. This finding could help unravel the mysteries of human longevity, as our cells may employ a similar biochemical mechanism.

Bacteria cells also exploit nitric oxide for their own purposes, Dr. Nudler has found. In a discovery that sheds light on antibacterial resistance, his team has revealed how the dangerous bacterial species Staphylococcus aureus and Bacillus anthracis manufacture nitric oxide and hydrogen sulfide to guard against oxidative stress and evade many different classes of antibiotics.

Among Dr. Nudler'
'/>"/>

Contact: Lisa Greiner
lisa.greiner@nyumc.org
212-404-3532
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. St. Jude scientist named Howard Hughes Medical Institute investigator
2. Using bacteria-eaters to prevent infections on medical implant materials
3. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
4. BUSM study shows positive impact of mind-body course on well-being of medical students
5. Quest for edible malarial vaccine leads to other potential medical uses for algae
6. New cutting-edge cell research will lead to safer medical experiments on humans
7. PeerJ launches PeerJ PrePrints -- a preprint server for the biological and medical sciences
8. Columbia University Medical Center/NY-Presbyterian experts at AAN
9. CWRU spinoff ConservoCare gets licensing options to develop medical device for bladder control
10. Paving the way for greater use of ancient medical knowledge
11. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... the University of Texas Medical Branch at Galveston ... treated with radiation for cervical cancer should begin ... , The UTMB researchers, finding a high incidence ... treated with radiation, offer new recommendations that the ... screening about eight years after their initial cervical ...
(Date:4/17/2014)... led by the Australian National University (ANU), have ... and deep-sea temperature variability over the past 5.3 ... understand the climate surrounding ice ages over the ... the relationship between carbon dioxide levels, global temperatures ... University of Southampton (UoS) and the National Oceanography ...
(Date:4/16/2014)... 20-year assessment of Nicaragua,s legal, artisanal green sea turtle ... catch rates of turtles in what may have become ... Wildlife Conservation Society and University of Florida. , During ... 170,000 green turtles were killed between 1991 and 2011, ...
Breaking Biology News(10 mins):Radiation therapy for cervical cancer increases risk for colorectal cancer 2Ancient sea-levels give new clues on ice ages 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 3
... cancer cells that survive chemotherapy leaving the door ... Institute scientists developed an original method for imaging and ... how a chemotherapy drug affects each one. ... and Eran Eden in the lab of Prof. Uri ...
... Munich, Germany and Ann Arbor, MI, USA, Jan 28 ... has joined the Illumina-Connect program, linking them to the ... new tools and applications for Illumina-generated data. , ... Munich, Germany commented: "As the industry,s only provider of ...
... observe in another but have never actually experienced yourself? A ... answer this question. The research, published by Cell Press in ... provides insight into brain mechanisms involved in empathy. Brain-imaging ... feel their own emotions or observe the same emotions in ...
Cached Biology News:Weizmann Institute scientists discover how cancer cells survive a chemotherapy drug 2Genomatix joins Illumina-Connect program 2I feel your pain: Neural mechanisms of empathy 2
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... , Jan. 14, 2014 The largest international ... medicinal plants and therapeutic derivatives thereof has endorsed ... and researchers about the challenges of adulterated herb ... ) The Society for Medicinal ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... Orange, CA (PRWEB) January 14, 2014 Kerr ... a 10-minute video and additional how-to information about dual arch ... Great Restorations with Dual Arch Impressions,” the blog entry serves ... the technique and houses a step-by-step demonstration by Dr. David ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Greg Schlicht and Dax Denman Join as Company ... Algenol Biofuels, developers of,DIRECT TO ETHANOL(TM), the ... continued growth of the company with the,appointments Greg ... General Counsel and Dax Denman as Senior Program ...
... Insmed Inc. (Nasdaq:,INSM) a developer of follow-on biologics ... of Insmed, will present at the,Biosimilars 2008 Conference ... Company,s perspective on the potential impact of follow-on ... a panel on this topic on,Tuesday, September 23, ...
... Study of More Than 60,000 Women Underscores Need for Better ... Implications and Risks Associated with Osteoporosis, MONTREAL, Sept. 15 ... (GLOW) showed that 55 percent of women,diagnosed with osteoporosis do ... their peers. This latest study from GLOW included more than,60,000 ...
Cached Biology Technology:Algenol Biofuels Further Strengthens Team With Key Appointments 2Insmed to Present at Biosimilars 2008 Conference 2Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 2Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 3
... Lauryl Ether 30% concentration ... Preservative. Surfactant. Clear Solution. ... is 1 mL of ... added to 400 mL ...
Mitotic Kinesin-Like Protein 1 (MKLP-1, KNSL5)...
... Contact Printing Kit contains choice of Printing Surface (3 ... over Ti adhesion layer, 1 silicon wafer coated with ... 3 plain glass slides) and PDMS Stamps (3 PDMS ... squares or 100 um x 10 mm or 200 ...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Biology Products: